Name
CLINICAL PARALLEL 6 - HBV Treatment Challenges and Controversies
Date & Time
Thursday, March 20, 2025, 8:30 AM - 10:00 AM
Speakers
Douglas Dieterich, Icahn School of Medicine at Mount Sinai
Edo Dongelmans, Erasmus MC
Rachel Wen-Juei Jeng, Chang Gung Memorial Hospital, Linkou Medical Center
Patrick Kennedy, Barts and The London School of Medicine & Dentistry, QMUL
Ariel Lee, Keck Medicine of USC
Anna Lok, University of Michigan
Description
  • Debate: Do Not Stop Long-Term NA Therapy in Absence of Functional Cure (against) Anna Lok
  • Debate: You Can Stop Long-Term Therapy in Absence of Functional Cure (for) Rachel Jeng
  • What is the Evidence for Expanding NA Therapy Patrick Kennedy
  • Oral Presentation: EARLY OFF-TREATMENT HBCRAG AND ANTI-HBC LEVELS IDENTIFY PATIENTS AT HIGH RISK OF SEVERE ALT FLARES AFTER NUCLEOS(T)IDE ANALOGUE WITHDRAWAL – A POOLED ANALYSIS OF TWO PROSPECTIVE STUDIES Edo Dongelmans
  • Oral Presentation: HEPATOCELLULAR CARCINOMA RISK IN HISPANICS WITH CHRONIC HEPATITIS B Ariel Lee
  • Oral Presentation: HBV-HIV CO-INFECTION & TENOFOVIR INTERRUPTION IN THE UNITED STATES: MONITORING PRACTICES AND INCIDENCE OF HEPATITIS B REACTIVATION OR HEPATITIS FLARE Douglas T. Dieterich
  • Q&A